Form 10-Q DEXCOM INC For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
DexCom (DXCM) PT Raised to $150 at Oppenheimer
November 7, 2018 9:35 AM ESTOppenheimer analyst Steven Lichtman raised the price target on DexCom (NASDAQ: DXCM) to $150.00 (from $125.00) while maintaining a Outperform rating.
The analyst commented, "DXCM's 3Q18 sales of $267M (+45% cc) beat our/consensus' $241/$243M, led by strong outperformance in International and better... More
